Results 111 to 120 of about 18,822 (191)

Financial De-Escalation in T1 Breast Cancers With the Low Magee Equation: An Experience From A Single Institution Without Genomic Testing. [PDF]

Eur J Breast Health
Lippe CE, Seltun F, Sandhu M, Barton K, Wert Y, Demirors B, Soran A, Lu K.   +7 more
europepmc   +1 more source

Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series. [PDF]

Cancer Rep (Hoboken), 2023
Sassi F, Rekaya MB, Belarbi A, Chilla D, Mansouri N, Achouri L, Saied E, Kassa R, Kacem LB, Ouezani M, Debabeche N, Rebhi F, Rammeh S.   +12 more
europepmc   +1 more source

Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics. [PDF]

Transl Oncol
Foffano L, Franzoni A, Molteni E, Giudici F, Dri A, Basile D, Cucciniello L, Buriolla S, Noto C, Russo S, Nascimbeni E, Bolzonello S, Pastò B, Rossa SD, Allegri L, Bonotto M, Minisini AM, Belletti B, Damante G, Gerratana L, Puglisi F.   +20 more
europepmc   +1 more source

Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. [PDF]

Arch Gynecol Obstet, 2023
Lukac S, Dayan D, Fink V, Leinert E, Hartkopf A, Veselinovic K, Janni W, Rack B, Pfister K, Heitmeir B, Ebner F.   +10 more
europepmc   +1 more source

Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach. [PDF]

Ther Adv Med Oncol
Russano F, Brugnolo D, Bottosso M, Dall'Olmo L, Del Fiore P, Baldan R, Ferrucci M, Musilli N, Vittoria Dieci M, Guarneri V, Rastrelli M, Mocellin S.   +11 more
europepmc   +1 more source

Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro Study. [PDF]

Cureus
Suizu E, Koyanagi T, Saga Y, Takahashi Y, Tamura K, Taneichi A, Takei Y, Mizukami H, Fujiwara H.   +8 more
europepmc   +1 more source

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2. [PDF]

Breast
Mazzoli G, Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Fotia G, De Monte M, Ligorio F, Jacobs F, Armani G, Zurlo C, Menichetti A, Griguolo G, Faso V, Schianca AC, Munzone E, Marra A, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, PALMARES-2 study group, Vernieri C.   +42 more
europepmc   +1 more source

[Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment]. [PDF]

Nervenarzt
Haußmann J, Goeckenjan M, Haußmann R, Wimberger P.   +3 more
europepmc   +1 more source

A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancer. [PDF]

Breast
van den Ende NS, Smid M, Martens JWM, Debets R, Jager A, van Deurzen CHM.   +5 more
europepmc   +1 more source

Estrogen and progesterone attenuate CD4-positive immune cell traffic to the penumbra region of rat's ischemic stroke brain. [PDF]

Iran J Basic Med Sci
Tamtaji A, Talaei SA, Naderian H, Atlasi MA, Alipour N, Azami Tameh A.   +5 more
europepmc   +1 more source